This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Includes the Inaugural North American Viral Hepatitis Elimination Summit

2019 Program 
8th Canadian Sympsium on Hepatitis C

friday May 24, 2019

7:15 AM - 7:00 PM
Registration/Breakfast Inscription, Petit Déjeuner

8:00 - 8:15 AM
Welcome and Introductions - Mot de Bienvenue
Naglaa Shoukry, Université de Montréal

8:15 - 9:50 AM
Session #1: Biomedical Research

Co-Chairs: Rod Russell, Memorial University & Vanessa Meier-Stephenson, University of Calgary

8:15 - 8:35 AM
Remaining Challenges in HCV Research, Ralf Bartenschalger, Heidelberg University
8:35 - 8:55 AM
Single-Cell RNA Sequencing to Describe the Cellular Microenvironment of the Liver, Sonya MacParland, University of Toronto
8:55 - 9:15 AM
Questions and Panel Discussion
9:15 - 9:27 AM
Targeting HCV-induced Epigenetic Reprogramming for HCC Chemoprevention Post Cure, Nourdine Hamdane, University of Strasbourg
9:27 - 9:39 AM
Identification of the Domain to which miR122 and Other Small RNAs Annealing Promotes the HCV Lifecycle, Rasika Kunden, University of Saskatchewan
9:39 - 9:51 AM
Analysis of Programmed Cell Death Induced by HCV Infection, Lingyan Wang, Memorial University

9:51 - 10:10
Coffee Break

10:10 - 11:34 AM
Session #2: Social, Cultural, Environmental and Population Health Research

Co-Chairs: Marina Klein, McGill University & Abdool Yasseen, University of Toronto

10:10 - 10:30 AM
Diagnostic Testing for Hepatitis C Infection: Where Are We Now and What Does the Future Hold, Stuart C. Ray, Johns Hopkins University School of Medicine
10:30 - 10:50 AM
Hepatitis C & HIV Testing from Dried Blood Spots: Simplifying Testing to Broaden Community Based Testing, John Kim, Public Health Agency of Canada
10:50 - 11:11 AM
Questions and Panel Discussion 11:11 - 11:22 AM: Estimation of an Individual-Level Deprivation Index for HIV/HCV Co-Infected Persons, Adam Palayew, McGill University
11:22 - 11:34 AM
Opioid Agonist Treatment and Risk of Hepatitis C Virus Infection Among People who Inject Drugs: The Overlooked Role of Dosage Adequacy, Andreea Adelina Artenie, Université de Montréal

11:34 - 1:00 PM
Lunch & Poster Sessions
Posters will be evaluated between

1:00 - 2:36 PM
Session #3: Clinical Research

Co-Chairs: Lisa Barrett, Dalhousie University & Sahar Saeed, McGill University

1:00 - 1:20 PM
Risk of HCC Following Hepatitis C Treatment, Hashem B. El-Seraq, Baylor College of Medicine
1:20 - 1:40 PM
Liver Fibrosis Staging in Hepatitis C, Keyur Patel, University Health Network
1:40 - 2:00 PM
Questions and Panel Discussion
2:00 - 2:12 PM
Never too Old to be DAA Treated for Hepatitis C, Curtis Cooper, University of Ottawa
2:12 - 2:24 PM
Feasibility of Rapid Hepatitis C Point-of-Care RNA Testing and Linkage to Care at an Integrated Supervised Consumption Site in Toronto, Canada, Bernadette Lettner, South Riverdale Community Health Centre
2:24 - 2:36 PM
Engaging Vulnerable, Treatment Naïve Persons Living with Hepatitis C in Same-Day Treatment, Shawn Greenan, Health PEI

2:36 - 2:56 PM
Coffee Break

2:56 - 5:15 PM
Session #4: Health Services Research

Co-Chairs: Naveed Janjua University of British Columbia & Aysegul Erman, University of Toronto

2:56 - 3:16 PM
Scaling Up HCV Screening & Diagnosis to Eliminate HCV, Jagpreet Chhatwal, Harvard Medical School
3:16 - 3:36 PM
Testing & Linkage with Care Strategies for HCV Among Immigrants & Newcomers, Christina Greenaway, McGill University
3:36 - 3:56 PM
Questions and Panel Discussion
3:56 - 4:08 PM
The Hepatitis C Virus (HCV) Cascade of Care in a Canadian Provincial Prison, Implications for HCV Micro-Elimination, Nadine Kronfli, McGill University
4:08 - 4:20 PM
State-Specific Direct Medical Costs of Hepatitis C in Ontario: A Population-Level Study, Alexander Haines, Toronto Health Economics and Technology Assessment Collaborative
4:20 - 4:32 PM
Assessment of Hepatitis C Screening Strategies in Different Community Settings in a Canadian Metropolitan Area, Camelia Capraru, Toronto Centre for Liver Disease/VIRCAN, UHN
4:32 - 5:15 PM
Improving Hepatitis C Diagnosis & Linkage to Care: Engaging Peers with Lived Experience in Programming & Research, Moderator: Chris Hoy, CATIE

5:15 - 5:25 PM
CanHepC Trainee Awards Ceremony

5:25 - 5:30 PM
CanHepC Symposium Closing Remarks Selena Sagan & Giada Sebastini, McGill University

5:30 - 5:40 PM
Canadian Liver Meeting Opening Remarks Marc Bilodeau, Université de Montréal

5:40 - 6:30 PM
Blueprint to Inform Hepatitis C Elimination Efforts in Canada
Jordan Feld, University of Toronto

6:30 PM
Canadian Liver Meeting Opening Reception